Cargando…

Enhanced Clostridioides difficile Infection Prevention With a Pharmacy-Controlled Policy That Adds a 3-Strain Lactobacillus Probiotic Concomitantly to Antibiotic Therapy

When 70% of antibiotic users took a 3-strain Lactobacillus probiotic preparation the hospital-wide rate of healthcare-associated Clostridioides difficile infection improved significantly. The incidence of C. difficile infection for those taking the probiotic along with multiple antibiotics or a sing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maziade, Pierre-Jean, Ship, Noam, Sniffen, Jason C, Goldstein, Ellie J C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528394/ https://www.ncbi.nlm.nih.gov/pubmed/33966076 http://dx.doi.org/10.1093/cid/ciab414

Ejemplares similares

Clostridioides difficile infection in a skilled nursing facility (SNF): cost savings of an automated, standardized probiotic antimicrobial stewardship programme (ASP) policy
por: Olson, Bridget, et al.
Publicado: (2023)

2568. Mechanisms of a Specific Probiotic Comprised of Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 that Interferes with Clostridioides difficile 20291 Toxin Production
por: Gunaratnam, Sathursha, et al.
Publicado: (2019)

Consortium of Probiotics Attenuates Colonization of Clostridioides difficile
por: Li, Xianping, et al.
Publicado: (2019)

Applications of Lactobacillus acidophilus-Fermented Mango Protected Clostridioides difficile Infection and Developed as an Innovative Probiotic Jam
por: Lee, Bao-Hong, et al.
Publicado: (2021)

Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI)
por: Kullar, Ravina, et al.
Publicado: (2020)

Lactobacillus Bacteremia and Probiotics: A Review
por: Kullar, Ravina, et al.
Publicado: (2023)

Microbiome-Related and Infection Control Approaches to Primary and Secondary Prevention of Clostridioides difficile Infections
por: McFarland, Lynne V., et al.
Publicado: (2023)

Frontiers in antibiotic alternatives for Clostridioides difficile infection
por: Phanchana, Matthew, et al.
Publicado: (2021)

Choosing an appropriate probiotic product for your patient: An evidence-based practical guide
por: Sniffen, Jason C., et al.
Publicado: (2018)

Influence of Probiotics on the Development of Clostridioides difficile Infection in Patients Receiving Fluoroquinolones
por: Sheffield, Mary E., et al.
Publicado: (2021)

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism
por: Koh, Elvin, et al.
Publicado: (2022)

Concomitant Clostridioides difficile and Edwardsiella tarda Infection in a Patient with Ulcerative Colitis
por: Fukuda, Hiromu, et al.
Publicado: (2022)

Antibiotic Resistance and Biofilm Production Capacity in Clostridioides difficile
por: Rahmoun, Layan Abu, et al.
Publicado: (2021)

2417. Feasibility and Safety of Using a Probiotic Comprised of Lactobacillus acidophilus CL1285, L. casei LBC80R and L. rhamnosus CLR2 for C. difficile Infection Prevention Among Antibiotic Users: 15-Years of Prospective Results from a Single-Center
por: Maziade, Pierre-Jean, et al.
Publicado: (2019)

381. Antibiotic Spectrum Index and Risk of Clostridioides difficile Infection
por: Ray, Michael J, et al.
Publicado: (2022)

Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action
por: Dysangco, Andrew T., et al.
Publicado: (2022)

Why 2 Studies That Used the Same Probiotic May Have Come Up With Different Outcomes
por: McFarland, Lynne V, et al.
Publicado: (2021)

A novel probiotic therapeutic in a murine model of Clostridioides difficile colitis
por: Shelby, Rita D., et al.
Publicado: (2020)

Role of probiotics in preventing Clostridioides difficile infection in older adults: an integrative review
por: Barbosa, Maria Lucianny Lima, et al.
Publicado: (2023)

The microbial diversity following antibiotic treatment of Clostridioides difficile infection
por: Binyamin, Dana, et al.
Publicado: (2021)

Antibiotic resistance and genomic features of Clostridioides difficile in southwest China
por: Gu, Wenpeng, et al.
Publicado: (2022)

Why Do ACG and AGA Guidelines Differ for the Use of Probiotics and the Prevention of CDI?
por: McFarland, Lynne V., et al.
Publicado: (2022)

Effects of Antibiotic Cycling Policy on Incidence of Healthcare-Associated MRSA and Clostridioides difficile Infection in Secondary Healthcare Settings
por: Conlon-Bingham, Geraldine Mary, et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis
por: Gulliver, Wayne P, et al.
Publicado: (2018)

Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection
por: De Wolfe, T. J., et al.
Publicado: (2018)

Is primary prevention of Clostridioides difficile infection possible with combination probiotics in elderly orthopedic patients?
por: NAGAMINE, Takahiko
Publicado: (2019)

In Vitro and In Vivo Anti-Clostridioides difficile Effect of a Probiotic Bacillus amyloliquefaciens Strain
por: Islam, Md Imtiazul, et al.
Publicado: (2022)

Personalized Clostridioides difficile engraftment risk prediction and probiotic therapy assessment in the human gut
por: Carr, Alex, et al.
Publicado: (2023)

Detection, Characterization and Antibiotic Susceptibility of Clostridioides (Clostridium) difficile in Meat Products
por: Muratoglu, Karlo, et al.
Publicado: (2020)

801. Patients with Clostridioides difficile Infection Following Dental Antibiotic Prescription
por: Wilson, Geneva M, et al.
Publicado: (2020)

Dietary fat promotes antibiotic-induced Clostridioides difficile mortality in mice
por: Hazleton, Keith Z., et al.
Publicado: (2022)

Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes
por: Lesniak, Nicholas A., et al.
Publicado: (2021)

661. In vitro Activity of Omadacycline and Comparator Antibiotics against Clostridioides difficile
por: Skinner, Andrew M, et al.
Publicado: (2022)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

2446. Longitudinal Results and Cost Savings Using a Bundle of C. difficile Infection Prevention Strategies in a Long-Term Care Facility
por: Olson, Bridget A, et al.
Publicado: (2019)

The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China
por: Zhang, Wen-Zhu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fr9endtf56h2s0cjr58hctv7j4